Lilach Aizenbud

Immune Checkpoint Inhibitor-Induced Hypophysitis and Patterns of Loss of Pituitary Function

Shlomit Jessel, Sarah A. Weiss, Matthew Austin et al. · Frontiers in Oncology · 2022 · 77 citations · Full text

Medicine, Oncology, Pharmacology +17

IL-7R licenses a population of epigenetically poised memory CD8 ⁺ T cells with superior antitumor efficacy that are critical for melanoma memory

Goran Micevic, Andrew Daniels, Karine Flem‐Karlsen et al. · Proceedings of the National Academy of Sciences · 2023 · 44 citations · Full text

Life Sciences, Immunology, Oncology +17

Impact of healthcare worker shift scheduling on workforce preservation during the COVID-19 pandemic

Dan M. Kluger, Yariv Aizenbud, Ariel Jaffe et al. · Infection Control and Hospital Epidemiology · 2020 · 43 citations · Full text

Management, Infectious Disease Control, Infectious Diseases +16

Germline genetic variants are associated with development of insulin-dependent diabetes in cancer patients treated with immune checkpoint inhibitors

Jasmine I. Caulfield, Lilach Aizenbud, Ana Luisa Perdigoto et al. · Journal for ImmunoTherapy of Cancer · 2023 · 19 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Humoral determinants of checkpoint immunotherapy

Yile Dai, Lilach Aizenbud, Kai Qin et al. · Nature · 2025 · 17 citations

Life Sciences, Immunology, Oncology +14